ArticleJournal of animal science and biotechnology2026
Yeast polysaccharides modulate lipid metabolism and restore oviduct inflammatory and microbial homeostasis to support egg quality in Salmonella Pullorum-challenged hens.
Article in Journal of animal science and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundOur previous work demonstrated that yeast polysaccharides (YP) possess prebiotic and immunomodulatory activity and improve performance, immunity via modulating gut microbiota in laying hens. Building on these findings, the present study examined whether YP additionally modulate layers lipid utilization and related metabolic signatures under basal conditions and mitigates oviduct dysfunction and egg-quality deterioration during Salmonella Pullorum challenge.
methodsA total of 288 Hy-Line Brown hens (35 weeks) were fed diets containing 0, 250, 500, or 1,000 mg/kg YP for 12 weeks. Egg quality and apparent total tract digestibility were recorded, and untargeted plasma metabolomics was performed in CON and YP1000 hens. Thereafter, hens from the CON and YP1000 groups were orally inoculated with S. Pullorum or saline, generating the CON, SAL, and YP + SAL groups. Post-challenge assessments included egg quality, magnum histology, oviductal albumen antimicrobial proteins, serum and oviduct cytokines, Salmonella load and LPS levels, and oviduct microbiota composition.
resultsUnder basal conditions, YP linearly increased yolk color at week 12 (ANOVA, P = 0.043; linear, P = 0.015; quadratic, P = 0.045) and enhanced ether-extract digestibility (ANOVA, P = 0.004; linear, P < 0.001; quadratic, P < 0.001). Metabolomics identified 16 differential metabolites; YP1000 elevated multiple LysoPC/LysoPE species, choline, taurine-conjugated bile acids, riboflavin, and nicotinamide, and decreased PE(38:6) (P < 0.05). Following S. Pullorum challenge, SAL hens showed reduced albumen height and Haugh unit, magnum epithelial disruption, heightened IL-1β and TNF-α responses, increased Salmonella and LPS burdens, reduced ovotransferrin and lysozyme levels, and a Proteobacteria-enriched, Lactobacillus-depleted oviduct microbiota (P < 0.05). YP supplementation mitigated these outcomes: YP + SAL hens maintained internal egg quality near control values, preserved magnum structure and antimicrobial protein secretion, increased serum IL-10 while normalizing IL-1β and TNF-α, reduced Salmonella and LPS levels, and displayed higher oviduct microbial diversity with enrichment of Lactobacillus and fewer opportunistic Proteobacteria (P < 0.05).
conclusionsYP not only improve lipid utilization and yolk pigmentation but also enhance the resistance of the oviduct-egg axis to S. Pullorum through coordinated modulation of host inflammation and oviduct microbial balance, offering a practical nutritional tool to support egg quality and safety in layer production.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.